Suprajit Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:24 pm

Quick Insight

Suprajit Engineering Ltd, with a share price of 445 and a market capitalization of 6,169 Cr., exhibits a high P/E ratio of 56.5, indicating the market's positive growth expectations. Despite a modest ROE of 7.51% and ROCE of 12.4%, the company maintains a healthy operating profit margin of 9%. With a net profit of 99 Cr. and significant reserves of 1,266 Cr., Suprajit Engineering appears to have a strong financial foundation. However, the company's high borrowings of ₹817 Cr. and a relatively long CCC of 98 days may warrant closer scrutiny to ensure efficient capital management and sustainable growth in the long term.

Competitors of Suprajit Engineering Ltd

All Competitor Stocks of Suprajit Engineering Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:55 am

Below is a detailed analysis of the quarterly data for Suprajit Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 863.00 Cr.. The value appears to be declining and may need further review. It has decreased from 877.00 Cr. (Mar 2025) to 863.00 Cr., marking a decrease of 14.00 Cr..
• For Expenses, as of Jun 2025, the value is 781.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 790.00 Cr. (Mar 2025) to 781.00 Cr., marking a decrease of 9.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2025) to 82.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 9.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 39.00 Cr., marking an increase of 29.00 Cr..
• For Interest, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.00 Cr. (Mar 2025) to 34.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2025) to 71.00 Cr., marking an increase of 21.00 Cr..
• For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be improving (decreasing) as expected. It has decreased from 46.00% (Mar 2025) to 32.00%, marking a decrease of 14.00%.
• For Net Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 48.00 Cr., marking an increase of 21.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.47. The value appears strong and on an upward trend. It has increased from 1.96 (Mar 2025) to 3.47, marking an increase of 1.51.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:55 pm

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: June 16, 2025, 11:16 am

Below is a detailed analysis of the balance sheet data for Suprajit Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,266.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,348.00 Cr. (Mar 2024) to 1,266.00 Cr., marking a decrease of 82.00 Cr..
• For Borrowings, as of Mar 2025, the value is 817.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 708.00 Cr. (Mar 2024) to 817.00 Cr., marking an increase of 109.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 636.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 550.00 Cr. (Mar 2024) to 636.00 Cr., marking an increase of 86.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,732.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,620.00 Cr. (Mar 2024) to 2,732.00 Cr., marking an increase of 112.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,011.00 Cr.. The value appears strong and on an upward trend. It has increased from 852.00 Cr. (Mar 2024) to 1,011.00 Cr., marking an increase of 159.00 Cr..
• For CWIP, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 19.00 Cr..
• For Investments, as of Mar 2025, the value is 251.00 Cr.. The value appears to be declining and may need further review. It has decreased from 513.00 Cr. (Mar 2024) to 251.00 Cr., marking a decrease of 262.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,445.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,249.00 Cr. (Mar 2024) to 1,445.00 Cr., marking an increase of 196.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,732.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,620.00 Cr. (Mar 2024) to 2,732.00 Cr., marking an increase of 112.00 Cr..

Notably, the Reserves (1,266.00 Cr.) exceed the Borrowings (817.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Suprajit Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.20. This value is within the healthy range. It has decreased from 12.08 (Mar 24) to 7.20, marking a decrease of 4.88.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.19. This value is within the healthy range. It has decreased from 12.06 (Mar 24) to 7.19, marking a decrease of 4.87.
• For Cash EPS (Rs.), as of Mar 25, the value is 16.12. This value is within the healthy range. It has decreased from 19.57 (Mar 24) to 16.12, marking a decrease of 3.45.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 93.34. It has decreased from 98.38 (Mar 24) to 93.34, marking a decrease of 5.04.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 93.34. It has decreased from 98.38 (Mar 24) to 93.34, marking a decrease of 5.04.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 238.91. It has increased from 209.15 (Mar 24) to 238.91, marking an increase of 29.76.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 27.68. This value is within the healthy range. It has increased from 27.65 (Mar 24) to 27.68, marking an increase of 0.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.79. This value is within the healthy range. It has decreased from 20.16 (Mar 24) to 18.79, marking a decrease of 1.37.
• For PBT / Share (Rs.), as of Mar 25, the value is 14.39. This value is within the healthy range. It has decreased from 16.45 (Mar 24) to 14.39, marking a decrease of 2.06.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.24. This value is within the healthy range. It has decreased from 12.08 (Mar 24) to 7.24, marking a decrease of 4.84.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.24. This value is within the healthy range. It has decreased from 12.08 (Mar 24) to 7.24, marking a decrease of 4.84.
• For PBDIT Margin (%), as of Mar 25, the value is 11.58. This value is within the healthy range. It has decreased from 13.22 (Mar 24) to 11.58, marking a decrease of 1.64.
• For PBIT Margin (%), as of Mar 25, the value is 7.86. This value is below the healthy minimum of 10. It has decreased from 9.63 (Mar 24) to 7.86, marking a decrease of 1.77.
• For PBT Margin (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 10. It has decreased from 7.86 (Mar 24) to 6.02, marking a decrease of 1.84.
• For Net Profit Margin (%), as of Mar 25, the value is 3.02. This value is below the healthy minimum of 5. It has decreased from 5.77 (Mar 24) to 3.02, marking a decrease of 2.75.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.02. This value is below the healthy minimum of 8. It has decreased from 5.77 (Mar 24) to 3.02, marking a decrease of 2.75.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.75. This value is below the healthy minimum of 15. It has decreased from 12.27 (Mar 24) to 7.75, marking a decrease of 4.52.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.97. This value is within the healthy range. It has decreased from 16.54 (Mar 24) to 15.97, marking a decrease of 0.57.
• For Return On Assets (%), as of Mar 25, the value is 3.63. This value is below the healthy minimum of 5. It has decreased from 6.48 (Mar 24) to 3.63, marking a decrease of 2.85.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.10, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.51. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 0.51, marking an increase of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.23. It has increased from 1.16 (Mar 24) to 1.23, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 1.5. It has decreased from 1.87 (Mar 24) to 1.45, marking a decrease of 0.42.
• For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.37 (Mar 24) to 0.95, marking a decrease of 0.42.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.66. This value is below the healthy minimum of 4. It has increased from 3.54 (Mar 24) to 3.66, marking an increase of 0.12.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 19.44 (Mar 24) to 0.00, marking a decrease of 19.44.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 12.00 (Mar 24) to 0.00, marking a decrease of 12.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 80.56 (Mar 24) to 0.00, marking a decrease of 80.56.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.00 (Mar 24) to 0.00, marking a decrease of 88.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.28. This value is within the healthy range. It has decreased from 7.45 (Mar 24) to 6.28, marking a decrease of 1.17.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 3. It has decreased from 4.26 (Mar 24) to 2.64, marking a decrease of 1.62.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,659.18. It has decreased from 6,205.70 (Mar 24) to 5,659.18, marking a decrease of 546.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 1.73, marking a decrease of 0.41.
• For EV / EBITDA (X), as of Mar 25, the value is 14.91. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 14.91, marking a decrease of 1.30.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.97 (Mar 24) to 1.57, marking a decrease of 0.40.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 80.55 (Mar 24) to 0.00, marking a decrease of 80.55.
• For Price / BV (X), as of Mar 25, the value is 4.02. This value exceeds the healthy maximum of 3. It has decreased from 4.18 (Mar 24) to 4.02, marking a decrease of 0.16.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.97 (Mar 24) to 1.57, marking a decrease of 0.40.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness